Detection of MDM2 alterations in cultured human hepatocytes treated with 17β-estradiol or 17α-ethinylestradiol

Anticancer Research

Volumn 22, Issue 3, 2002, Pages 1545-1552

  Schlott, Thilo ^a   Thasler, Wolfgang ^a   Gorzel, Carolin ^a   Pahernik, Sascha ^a   Brinck, Ulrich ^a   Eiffert, Helmut ^a   Droese, Manfred ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

17 ethinylestradiol; 17 estradiol; Hepatocytes; MDM2

Indexed keywords

ESTRADIOL; ETHINYLESTRADIOL; MESSENGER RNA; PROTEIN MDM2; STEROID HORMONE;

ADULT; AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE MUTATION; HORMONE ACTION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LIVER CELL; LIVER CELL CULTURE; MALE; ONCOGENE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING;

ADULT; CELL TRANSFORMATION, NEOPLASTIC; DNA MUTATIONAL ANALYSIS; ESTRADIOL; ESTRADIOL CONGENERS; ETHINYL ESTRADIOL; HEPATOCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0036327251     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Tumorigenic potential associated with enhanced expression of a gene that is amplified in mouse tumor cell line
2. Amplification of a gene encoding a p53 associated protein in human sarcomas
3. Human oncoprotein MDM2 interacts with the TATA-binding protein in vitro and in vivo
4. Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein
5. The MDM2 C-terminal region binds to TAFII250 and is required for MDM2 regulation of the cyclin A promoter
6. MDM2 and p53: A question of balance
7. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
8. MDM2 gene amplification in metastatic osteosarcoma
9. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53
10. E2F1-specific induction of apoptosis and p53 accumulation which is blocked by Mdm2
11. The mdm-2 oncogene can overcome wild-type p53 suppression of transformed cell growth
12. The transforming activities of MDM2 in cultured neonatal rat astrocytes
13. Point mutations and nucleotide insertions in the MDM2 zinc finger structure of human tumours
14. Different expression of MDM2, GAGE-1, -2 and FHIT in hepatocellular carcinoma and focal nodular hyperplasia
15. Physical and functional interaction between wild-type p53 and mdm2 proteins
16. Alternatively spliced mdm2 transcripts with loss of p53 binding domain sequences: Transforming ability and frequent detection in human cancer
17. Short alternative splice transcripts of the mdm2 oncogene correlate to malignancy in human astrocytic neoplasms
18. Pathology of hepatocellular carcinoma
19. Sex hormonal preparations and the liver
20. Oral contraceptive steroids as promoters of hepatocarcinogenesis in female Sprague-Dawley rats
21. Isolation and long-term culture of human hepatocytes
22. Metabolism of pimobendan in long-term human hepatocyte culture: In vivo/in vitro comparison
23. Immunoenzymatic labeling of monoclonal antibodies using immune complex of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes)
24. Risk factors for breast cancer
25. Clinical aspects of risk in women with endometrial carcinoma
26. Clinical and pathological comparison of young adult women with hepatocellular carcinoma with and without exposure to oral contraceptives
27. 17Beta-estradiol-induced cell transformation and aneuploidy of Syrian hamster embryo cells in culture
28. Neoplastic transformation of cultured mammalian cells by estrogens and estrogenlike chemicals
29. Effects of 17 beta-estradiol on c-myc and c-Ha-ras expression in the liver of ovariectomized female rats
30. Differential expression of the estrogen-regulated proto-oncogenes c-fos, c-jun, and bcl-2 and of the tumor suppressor p53 gene in the male mouse chronically infected with Taenia crassiceps cysticerci
31. Hepatocellular carcinoma in alcoholic cirrhosis: Is sex hormone imbalance a pathogenic factor?
32. The p53-binding protein MDM2 gene is differentially expressed in human breast carcinoma
33. Regulation of tumor suppressor proteins, p53 and retinoblastoma, by estrogen and antiestrogens in breast cancer cells
34. Over-expression of MDM2 in MCF-7 promotes both growth advantage and p53 accumulation in response to estradiol
35. Cyclin A2 and c-myc mRNA expression in ethinyl estradiol induced liver proliferation
36. Dose-response relationships in promotion of rat hepatocarcinogenesis by 17 alpha-ethinylestradiol
37. The expression of the mdm2 gene may be related to the aberration of the p53 gene in human hepatocellular carcinoma
38. Infrequent mutations of the TP53 gene and no amplification of the MDM2 gene in hepatoblastomas
39. Oestradiol and testosterone blood levels in patients with viral cirrhosis and hepatocellular carcinoma
40. The human oncoprotein MDM2 arrests the cell cycle: Elimination of its cell-cycle-inhibitory function induces tumorigenesis
41. The MDM2 oncoprotein binds specifically to RNA through its RING finger domain
42. MDM2 interacts with MDMX through their RING finger domains
43. Evidence for the DNA binding and adduct formation of estrone and 17beta-estradiol after dimethyldioxirane activation
44. 32-Postlabeling analysis of DNA adducts in rats during estrogen-induced hepatocarcinogenesis and effect of tamoxifen on DNA adduct level
45. Formation of DNA-adducts by selected sex steroids in rat liver